Internal Medicine, Cardiovascular Disease · Birmingham, AL
NPI
1114982261
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
801 Princeton Ave SW, Suite 706
Birmingham, AL, 35211
Phone (205) 780-4330
Groups this clinician bills Medicare through
Medicare paid, 2024
$551K
7,381 services
Medicare patients, 2024
930
Average age 76
Drug cost, 2024
$2.3M
12,829 prescriptions
Company payments, 2025
$955
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Sibley was code 99214 (office e&m - established), 947 times for 548 patients. In total David H Sibley billed 7,381 services in 70 codes, and Medicare paid $551K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 947 | 548 | $80.28 | $76K |
| 93000 Electrocardiogram | Office | 907 | 514 | $9.14 | $8,288 |
| 99233 Hospital E&M - Subsequent | Facility | 859 | 236 | $86.87 | $75K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 452 | 110 | $4.72 | $2,134 |
| 93296 External Electrocardiographic Monitoring | Office | 284 | 95 | $12.50 | $3,551 |
| 93306 Echocardiography (TTE/TEE) | Office | 261 | 257 | $126.58 | $33K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 212 | 104 | $229.51 | $49K |
| 93306 Echocardiography (TTE/TEE) | Facility | 208 | 203 | $46.06 | $9,581 |
| 93294 External Electrocardiographic Monitoring | Office | 204 | 69 | $17.99 | $3,670 |
| 93015 Electrocardiogram | Office | 165 | 160 | $46.69 | $7,704 |
| 99152 Anesthesia | Facility | 124 | 109 | $8.80 | $1,091 |
| 99223 Hospital E&M - Initial | Facility | 115 | 108 | $120.45 | $14K |
| 78431 Myocardial Perfusion Scan | Office | 106 | 104 | $1,617.48 | $171K |
| 99222 Hospital E&M - Initial | Facility | 89 | 83 | $89.98 | $8,009 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 84 | 83 | $124.90 | $10K |
By year: 2022 $506K for 5,215 services; 2023 $651K for 6,811 services; 2024 $551K for 7,381 services.
Medicare prescription drug claims, 2024
In 2024, the drug David H Sibley prescribed most often to Medicare patients was Amlodipine Besylate, with 1,165 prescriptions and refills. In total David H Sibley wrote 12,829 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,165 | 3,082 | 386 | $8,396 |
| Carvedilol Generic | 1,035 | 2,693 | 315 | $11K |
| Furosemide Generic | 972 | 2,503 | 333 | $5,770 |
| Metoprolol Succinate Generic | 959 | 2,541 | 303 | $17K |
| Eliquis Apixaban | 663 | 1,008 | 134 | $576K |
| Atorvastatin Calcium Generic | 525 | 1,374 | 163 | $7,716 |
| Entresto Sacubitril/Valsartan | 518 | 751 | 107 | $452K |
| Losartan Potassium Generic | 507 | 1,282 | 163 | $6,991 |
| Farxiga Dapagliflozin Propanediol | 404 | 514 | 105 | $287K |
| Potassium Chloride Generic | 356 | 874 | 124 | $8,770 |
| Ranolazine Er Ranolazine | 304 | 631 | 74 | $35K |
| Chlorthalidone Generic | 292 | 724 | 90 | $6,517 |
| Lisinopril Generic | 249 | 688 | 87 | $1,908 |
| Repatha Sureclick Evolocumab | 228 | 333 | 44 | $181K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 213 | 613 | 75 | $4,414 |
Brand drugs: 2,657 claims; generic drugs: 10,172 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Sibley $955 ($955 in general payments such as food, travel and fees) from 14 companies. The largest payer was Boston Scientific Corporation with $336.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 23 | $336 |
| Pfizer Inc. PFE | 9 | $177 |
| Amgen Inc. AMGN | 5 | $73 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $59.01 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $57.25 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $53.92 |
| Novo Nordisk Inc NVO | 3 | $46.5 |
| Biosense Webster, Inc. JNJ | 1 | $40.34 |
| AngioDynamics, Inc. ANGO | 1 | $29.7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.